Publicacións (96) Publicacións de MARÍA JOSÉ HERRERO CERVERA

2024

  1. Implementation of pharmacogenetics in primary care

    Atencion Primaria

  2. Safe Procedure for Efficient Hydrodynamic Gene Transfer to Isolated Porcine Liver in Transplantation

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy

    Cancers, Vol. 15, Núm. 5

  3. Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain

    Journal of Clinical Medicine, Vol. 12, Núm. 10

2022

  1. Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines

    Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 483-494

  2. Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder

    Mechanisms of Ageing and Development, Vol. 204

  3. Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia

    HLA, Vol. 99, Núm. 2, pp. 93-104

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  5. Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up

    Pharmaceutics, Vol. 14, Núm. 2

  6. Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives

    Pharmaceutics, Vol. 14, Núm. 3

  7. Study of Oligonucleotides Access and Distribution in Human Peripheral Blood Mononuclear Cells

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

2021

  1. Foxp3 silencing with antisense oligonucleotide improves immunogenicity of an adjuvanted recombinant vaccine against sporothrix schenckii

    International Journal of Molecular Sciences, Vol. 22, Núm. 7

  2. High-throughput genotyping of HLA-G, HLA-F, MICA, and MICB and analysis of frequency distributions in healthy blood donors from Catalonia

    HLA, Vol. 97, Núm. 5, pp. 420-427

  3. Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

    Leukemia and Lymphoma, Vol. 62, Núm. 3, pp. 659-668

  4. Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia

    Pharmacogenetics and Genomics, Vol. 31, Núm. 6, pp. 133-139

  5. Integrated cgh/wes analyses advance understanding of aggressive neuroblastoma evolution: A case study

    Cells, Vol. 10, Núm. 10

  6. Mitochondrial dna replacement techniques to prevent human mitochondrial diseases

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-23

  7. Multicompartmental lipopolyplex as vehicle for antigens and genes delivery in vaccine formulations

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-20

  8. Pharmacogenetics in neuroblastoma: What can already be clinically implemented and what is coming next?

    International Journal of Molecular Sciences, Vol. 22, Núm. 18